--- a
+++ b/clusters/9knumclustersv2/clust_1316.txt
@@ -0,0 +1,22 @@
+Uncontrolled diabetes mellitus: hemoglobin Ac (HbAc) must be < % or there must be documentation that control has been good for the week prior to study entry, with daily morning glucoses at <  mg/dl; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by glycosylated hemoglobin (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by glycosylated hemoglobin (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by glycated hemoglobin (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > .% despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by HbAc >% despite adequate therapy. Patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and anti-diabetic treatment must be monitored closely throughout the trial and adjusted as necessary.
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus defined as hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus may be included; however, blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin (Hb)Ac > % despite adequate therapy; note: patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and anti-diabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) greater than % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Patients with uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+EXPANSION COHORT ONLY: Uncontrolled diabetes mellitus as defined by HbAc > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin, alpha  (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by glycated hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and anti-diabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by hemoglobin Ac (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by glycated hemoglobin (HbAc) > % despite adequate therapy; patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary
+Uncontrolled diabetes mellitus as defined by HbAc >% despite adequate therapy. Patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary;